Resveratrol is a polyphenol stilbenoid found in the skin of red grapes, in red wine, in peanuts, and in the roots of Polygonum cuspidatum (Japanese knotweed), the primary commercial source of resveratrol supplements. It achieved widespread scientific attention in the early 2000s when it was shown to activate SIRT1 (sirtuin 1) — one of the seven sirtuin enzymes that regulate cellular ageing, DNA repair, and metabolism — and to extend lifespan in yeast, worms, flies, and fish. In mammals, resveratrol’s effects are more nuanced: it clearly modulates SIRT1 activity, extends healthspan, and improves numerous biomarkers of metabolic health, but its lifespan extension effects in mammals remain controversial.
The SIRT1 Mechanism
SIRT1 is an NAD+-dependent deacetylase — an enzyme that removes acetyl groups from proteins in a reaction that requires NAD+ as a co-substrate. When SIRT1 is activated, it deacetylates a wide range of target proteins — including p53 (reducing its activity and therefore reducing apoptosis), PGC-1alpha (enhancing mitochondrial biogenesis), FOXOs (the forkhead transcription factors that regulate stress resistance and longevity), and NF-kB (reducing its activity and therefore reducing inflammation). This broad deacetylation activity means that SIRT1 activation produces a coordinated shift toward stress resistance, efficient metabolism, and cellular longevity.
Metabolic Health and Cardiovascular Effects
The most consistently reproduced effect of resveratrol in humans is the improvement in metabolic health markers — specifically, improvements in insulin sensitivity, reductions in blood pressure, and reductions in hepatic fat accumulation in people with metabolic syndrome and type 2 diabetes. A meta-analysis of 21 RCTs found that resveratrol supplementation at doses of 150-500mg daily significantly reduced fasting glucose, insulin, and HOMA-IR in people with metabolic disease. For cardiovascular health, resveratrol has been shown to improve endothelial function at doses of 250-500mg daily — an effect consistent with its activation of SIRT1 in endothelial cells and the consequent production of nitric oxide.
The Bioavailability Problem and Solution
Resveratrol has notoriously poor oral bioavailability due to rapid metabolism in the liver and intestinal wall — only approximately 1% of an oral dose reaches systemic circulation as free resveratrol. However, this does not necessarily negate its therapeutic efficacy. To improve bioavailability, newer formulations combine resveratrol with piperine (the active compound in black pepper, which inhibits the glucuronidation of resveratrol), or use a liposomal/phospholipid complex form of resveratrol. A standard formulation called “resveratrol 3-5% PE” refers to 3-5% piperine-enhanced resveratrol, which shows 30-50% improved bioavailability compared to standard resveratrol.
Dosing and Practical Application
The evidence-based dose for metabolic and cardiovascular applications is 250-500mg of resveratrol daily, ideally in a piperine-enhanced formulation or taken with a fat-containing meal. For cognitive applications, higher doses of 500-1000mg daily are used because the blood-brain barrier penetration of resveratrol is limited. Resveratrol should not be combined with anticoagulants (warfarin, clopidogrel) without close monitoring due to its antiplatelet effects. Otherwise, resveratrol is well-tolerated with occasional reports of mild GI discomfort at higher doses.
What the Research Actually Shows
Nutritional science in this area has advanced significantly over the past decade, with larger-scale randomised controlled trials replacing the small observational studies that dominated earlier literature. The best-designed studies in this field now use objective biomarkers rather than subjective self-reports, and the consensus emerging from this more rigorous research is that the compound in question has meaningful physiological effects at appropriate doses — but that bioavailability, formulation quality, and individual variation in absorption substantially affect outcomes in practice. Not all supplements are created equal, and the gap between research-grade and commercial formulations can be significant.
Mechanism of Action
This compound works through multiple intersecting biochemical pathways. The primary mechanism involves modulation of the gut-brain axis — a bidirectional communication network linking intestinal permeability, microbial composition, and neurological inflammation. By influencing gut barrier integrity and microbial metabolites, it affects systemic inflammation levels that in turn influence brain function. A secondary mechanism involves direct activity at neurotransmitter systems or cellular metabolism pathways, providing a multi-target profile that is characteristic of many effective nutritional interventions.
Key Practical Considerations
Dosage and formulation are the two most important practical variables. Most research uses doses that are difficult to achieve through standard dietary intake, meaning that supplementation is typically necessary for therapeutic effects. The form matters substantially — some compounds have poor bioavailability in certain formulations, and the difference between a highly absorbable form and a poorly absorbed form can be a tenfold difference in blood levels at equivalent doses. Working with a knowledgeable practitioner to guide supplementation is the most reliable way to ensure appropriate dosing.
Leave a Reply